Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-05 06:11 am Purchase | 2025-12-10 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 2,847,837 4.000% | 34,000 (+1.21%) | Filing History |
| 2026-03-05 06:04 am Sale | 2025-04-28 | 13D | JADE BIOSCIENCES, INC. JBIO | Sofinnova Venture Partners X, L.P. ("SVP X") | 107,391 0.300% | -1,389 (-1.28%) | Filing History |
| 2024-03-26 7:57 pm Sale | 2024-03-22 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 2,813,837 5.400% | -834,459 (-22.87%) | Filing History |
| 2024-02-20 7:11 pm Purchase | 2024-01-30 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 3,648,296 6.900% | 171,215 (+4.92%) | Filing History |
| 2024-02-20 7:11 pm Purchase | 2023-07-28 | 13D | INOZYME PHARMA INC INZY | Sofinnova Venture Partners X, L.P. ("SVP X") | 4,280,308 6.900% | 2,252,000 (+111.03%) | Filing History |
| 2024-02-20 7:09 pm Purchase | 2023-06-21 | 13D | AEROVATE THERAPEUTICS INC AVTE | Sofinnova Venture Partners X, L.P. ("SVP X") | 108,780 13.800% | 676 (+0.63%) | Filing History |
| 2023-06-20 8:56 pm Sale | 2023-06-14 | 13D | KARUNA THERAPEUTICS INC KRTX | Sofinnova Venture Partners X, L.P. ("SVP X") | 1,439,649 3.800% | -386,975 (-21.19%) | Filing History |
| 2023-03-01 1:38 pm Sale | 2023-02-24 | 13D | CINCOR PHARMA INC CINC | Sofinnova Venture Partners X, L.P. ("SVP X") | 0 0.000% | -6,109,360 (Position Closed) | Filing History |
| 2023-02-13 8:43 pm Purchase | 2023-02-06 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 3,477,081 8.300% | 285,714 (+8.95%) | Filing History |
| 2023-02-03 7:24 pm Purchase | 2022-11-14 | 13D | AEROVATE THERAPEUTICS INC AVTE | Sofinnova Venture Partners X, L.P. ("SVP X") | 108,104 15.400% | 673 (+0.63%) | Filing History |
| 2023-02-03 7:11 pm Purchase | 2023-01-12 | 13D | KARUNA THERAPEUTICS INC KRTX | Sofinnova Venture Partners X, L.P. ("SVP X") | 1,826,624 5.300% | 97,272 (+5.62%) | Filing History |
| 2023-02-03 7:07 pm Purchase | 2022-03-28 | 13D | VERA THERAPEUTICS INC VERA | Sofinnova Venture Partners X, L.P. ("SVP X") | 3,191,367 11.500% | 276,591 (+9.49%) | Filing History |
| 2022-08-19 5:38 pm Purchase | 2022-08-11 | 13D | CINCOR PHARMA INC CINC | Sofinnova Venture Partners X, L.P. ("SVP X") | 6,109,360 14.300% | 535,411 (+9.61%) | Filing History |
| 2022-02-14 6:45 pm Purchase | 2021-11-04 | 13D | Y-MABS THERAPEUTICS INC YMAB | Sofinnova Venture Partners X, L.P. ("SVP X") | 2,271,611 5.200% | 160,222 (+7.59%) | Filing History |
| 2022-01-21 3:19 pm Purchase | 2022-01-11 | 13D | CINCOR PHARMA INC CINC | Sofinnova Venture Partners X, L.P. ("SVP X") | 5,573,949 15.300% | 5,573,949 (New Position) | Filing History |